Back

Pharma

2nd Sustainable Medicine & Environment Conference

  • 22nd – 23rd May 2024
  • Germany flag Germany Munich
  • Eurostars Grand Central Arnulfstraße 35, 80636

Join us in Munich for the 2nd Sustainable Medicine & Environment Summit on May 22-23, 2024, where industry leaders, researchers, and policymakers will explore the intersection of pharmaceutical manufacturing, technology, and environmental sustainability. Discover green solutions, renewable energy integration, and eco-friendly drug development. This exciting event brings together leaders, researchers, and policymakers to explore how pharmaceutical manufacturing and technology can be more sustainable.

Read more

About 2nd Sustainable Medicine & Environment Conference

Discover the latest advancements in sustainable pharmaceutical processes, green chemistry applications, and resource-efficient drug development. Learn from experts about waste reduction, circular economy practices, and renewable energy integration in pharma facilities. We'll explore green packaging alternatives and delve into water conservation and management strategies for the pharmaceutical industry.

Delve into lifecycle assessments of pharmaceuticals and embrace green practices to make a positive impact on the environment.

Connect with like-minded professionals to discuss eco-friendly drug delivery systems and the crucial role of biodiversity in human health. Explore how the One Health approach can lead to groundbreaking collaborations between medicine, the environment, and technology. 

Who Should Attend   

Executives, Directors, Heads, Leaders, Managers, Specialists, Engineers Professionals in Pharmaceuticals, Principal Scientists, Sustainable Regulatory, QC Laboratories, Manufacturers of Drug Substances (APIs), Contract Laboratories, Health & Human Services, Clinical Research Org., Healthcare Packaging, Contract Research Org., Contract Manufacturing Org., Biopharma Companies, Biotechnology Prod., and Fellows specialising in:   

  • Sustainability
  • Environment 
  • Carbon Neutrality
  • Regulatory Affairs 
  • Waste Control 
  • Recycling and Reusing
  • Raw Materials Minimisation
  • Process Optimisation
  • Process Development
  • Eco-Friendly Manufacturing 
  • Waste Reduction
  • Containment Development 
  • Compliance 
  • Labelling 
  • Chemicals 
  • Manufacturing Science and Technology 
  • Product Development 
  • Risk Management 
  • Safety Assessments 
  • Supply Chain 
  • Technology Transfer   
  • Controls & Robotics 
  • Drug Development 
  • Materials Science & Selection 
  • Medical Devices 
  • Standardisation 
  • Vaccines  
  • Validation   
  • Production  
  • EHS    
  • QA/QC   
  • CMC   
  • CMO/CDMO

 

Register by end of April

The Early Bird Offer expires in 7 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

Key Practical Learning Points

  • Exploring innovative and eco-friendly technologies for drug production to reduce environmental impact and carbon footprint
  • Advancing the application of green chemistry principles to design environmentally benign pharmaceutical processes
  • Strategies to minimise waste generation, optimise resource utilisation, and promote circular economy practices in pharmaceutical manufacturing
  • Showcasing successful examples and encouraging the adoption of renewable energy sources in pharmaceutical production plants
  • Addressing the environmental impact of pharmaceutical packaging and promoting sustainable alternatives
  • Implementing water-saving technologies and sustainable water management practices in pharmaceutical production
  • Evaluating the environmental impact of drugs throughout their life cycle and identifying areas for improvement
  • Promoting sustainable practices across the pharmaceutical supply chain, from raw materials to distribution
  • Harnessing digital technologies and artificial intelligence to optimise drug discovery and development processes, reducing resource consumption
  • Advancing research and development of eco-friendly drug delivery systems, such as biodegradable polymers and nanotechnology-based systems

Register by end of April

The Early Bird Offer expires in 7 days!

Dr. Ester Lovsin Barle, CH

Global Head Product Sustainability and Stewardship

Takeda

Ester Lovsin Barle, DVM, MSc, PhD, MScTox is the global head of product sustainability and stewardship and at Takeda Pharmaceuticals. She lives in Zurich, Switzerland.

Ester is passionate about generating value with product safety and sustainability. She is leading the cross-organizational product sustainability workstream sustainability by design for the planet pillar of purpose-led sustainability in Takeda. Her responsibilities also include product stewardship topics, such as safety data sheet process, maintaining article and material regulatory compliance and scientific development and cross-organisational implementation of health-based exposure limits (HBEL) in support of research and manufacturing in Takeda globally. Previously she has held corporate positions at Lonza and Novartis. She has been working in the pharmaceutical industry for over 15 years. She received her PhD in veterinary sciences from University of Ljubljana, Slovenia, and a second master’s degree in toxicology and risk assessment from Medical University in Vienna. Ester is a certified toxicologist.

Jürgen Wieland, CH

Development Environmental Sustainability Lead

Novartis

Novartis has set ambitious environmental sustainability targets to achieve carbon neutral own operations by 2025, plastic neutrality and water sustainability by 2030, and net-zero by 2040.  Novartis was recently recognized by CDP as the only big pharma company globally with a Double-A leadership rating in the Climate Change and Water Security categories.

Jürgen’s role as Environmental Sustainability lead for Novartis’ global development organization covers the set-up and execution of low carbon clinical trials. On top, Jürgen is in charge of the company-wide target of “all new products meet sustainable design principles by 2030”, which spans from research up to commercial.  Jürgen represents Novartis within two workstreams of the Sustainable Markets Initiative (SMI) Health System Task Force and within the Sustainable Healthcare Coalition’s industry low carbon clinical trial workstream.

Jürgen has been very engaged and passionate about the topic of environmental sustainability for more than three decades. Prior to joining Novartis in 2011, he was the CFO of the NGO Solar Energy Foundation, supporting the roll-out of solar energy in rural East Africa. From 2015-20, he was the finance head of Novartis’ global clinical supply unit, during which he was awarded with the Novartis “Better World Award for Environmental Sustainability” for significant progress in the decarbonisation of clinical trials.

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Dr. Michael Hell is a chemist (MSc) and cell biologist (PhD) by education with substantial experience in manufacturing and operations of biopharmaceuticals. Before being appointed to head of sustainability at Merck’s Healthcare operations, he was leading environment, health, and safety for Merck KGaA’s global biotech manufacturing and led a packaging, logistics, and visual inspection operation unit.

Michael brings a diverse background in manufacturing, spanning environment, health, and safety, strategy development, continuous improvement/LEAN, operations, and business consulting. He is an active member of ISPE and chaired conference tracks or contributed as speaker. Michael co-authored scientific papers or book chapters.

Courtney Soulsby, UK

Global Director, Pharmaceutical Sustainability

British Standards Institution (BSI)

Courtney Soulsby works as a global director for the healthcare and life sciences sector team for British Standards Institution (BSI), focussing on pharmaceutical sustainability. Working to understand market challenges and future needs of the healthcare sector, Courtney works with key clients and industry partners to develop holistic solutions, strategies, and programs. Courtney has worked with the pharmaceutical industry and their supply chain for over 10 years – with a deep understanding of the issues with regulation, environment, security, compliance, quality, and other risk exposures when manufacturing and transporting medicines.

Richard Hall Hall, ES

Business Development/Chair – ASTM E55.11 Process Design

Rattiinox

Richard Hall is a mechanical engineer with several decades experience in the hydraulics industry - selling hydraulic cylinders to global manufacturers of construction and agricultural equipment (Caterpillar, John Deere, Kubota, Bobcat, etc.). He provides active, hands-on managerial support of continuous process improvement methods (SMED, 5S, Kaizen, VSM, etc.) and introduction of new production processes.

Richard has works in business development for Rattiinox (aseptic valve manufacturer) and is a non-voting member of four ASME BPE task groups: CIP, Valve certification, Appendix K (valve testing), and vessel certification. He's also been a member of ISPE since 2011, as well as PDA, A3P, and ASTM E55 since 2021.

He's the technical lead of ASTM E55.11: Clean by Design task group (80 members), and he's writing new standards for the specification, design, manufacture, and FAT test (CIP-cleanability test - not just coverage test) of pharmaceutical manufacturing systems that are rapid to clean robustly with CIP, using 50-80% less water and energy. Richard is also the chair of ASTM E55 subcommittee E55.11 Process Design.

Dr. Clare Mayes, FL

Sustainability Project Leader

AstraZeneca

Clare Mayes, PhD, is a sustainability project leader within AstraZeneca, leading a diverse range of projects across AstraZeneca's environmental sustainability programme ensuring the delivery of key attributes of AstraZeneca's ambitious greenhouse gas reduction targets.

Clare has a BSc and MSc in chemistry and a PhD in chemical engineering and prior to moving into sustainability Clare spent 15 years in process development and manufacturing in the pharmaceutical industry. She joined AstraZeneca from GSK in 2016 to lead crystallisation and materials science in the on-market group. She has a track record of successfully leading projects and teams to deliver complex understanding and process change programmes from API development through to final pack manufacture. The breadth of background puts Clare in an excellent position to understand the challenges to making the manufacture of medicines more sustainable.

Christopher Nial, IR

Senior Partner, EMEA Public Health Co-Lead

FINN Partners

Christopher Nial is a senior partner at FINN Partners and is based in Ireland. His career, spanning over three decades, is marked by a deep commitment to enhancing global public health. Christopher’s journey in this field is distinguished by his unique focus on the critical intersection of climate change and public health. This specialised approach reflects his belief in the profound impact of environmental factors on global health outcomes.

His collaborations with both profit and non-profit organisations further highlight Christopher's impact. He has played a pivotal role in advancing the missions of major pharmaceutical giants like MSD, Sanofi, GSK, and Roche, and influential non-profits such as the Bill & Melinda Gates Foundation, Gavi, and PATH. His contributions to these organisations underscore his dedication to shaping a healthier, more sustainable future, making him a respected figure in global public health and climate advocacy.

Baijia Huang, DK

Global Environmental Lead

Novo Nordisk

Baijia Huang is leading “Design Devices and Packaging for Circularity” in Novo Nordisk, and responsible for translating Novo Nordisk’s plastic strategy into tangible targets and initiatives and embedding circularity principles into product development. She has over 10 years of experience within environmental sustainability and circular economy across different sectors.

She brings a variety of environmental capabilities including decarbonisation in production, scope 3 emission reduction, and take-back and recycling schemes. Baijia worked as group sustainability manager for an insulation material manufacturer in Denmark, where she was responsible for strengthening their circular economy business model. She was participating in harmonisation of life cycle assessment methods for the construction industry, and actively engaging external stakeholders and thought leaders on sustainability and circularity. Moreover, she worked over six years as a consultant to the European Commission on ecodesign legislations, carrying out impact assessments and review studies that supported the policymaking.

Sam Maguire, UK

Sustainability & Impact lead

Clarasys

Sam Maguire is a principal consultant who specialises in sustainability strategy and operating model design across multiple industries. He has particular expertise in sustainable business models, designing organisations to be more circular, and supply chain transformation. He works across the pharmaceuticals, financial services, and food and beverage industries.  

Ilaria Lo-Presti, UK

Head of Sustainability Engineering, Centre of Excellence

GSK

Ilaria Lo-Presti is a civil and structural engineer with a master’s degree in project management working for GSK as head of environmental engineering in their centre of excellence, leading a team of engineers and experts at a global level to deliver operational sustainability for GSK.

Over the last 12 years, she has acquired broad knowledge of the pharmaceutical engineering field, following important projects and constructions within Europe and globally, from feasibility study through to the qualification stage.

Ilaria has been employed by a range of companies (i.e. engineering consultants, equipment manufacturer, and big pharma), allowing her to gain further knowledge of the challenges when working across different environments, organisations, and cultures.

Bernd Mahlmann, CH

Associate Director, Account & Business Development

Ypsomed AG

Bernd Mahlmann, executive MBA, is a senior business development leader who’s been enabling customer-centric transformation and driving growth in the international pharma and medical device industries for more than 15 years. At Ypsomed, Bernd also has a particular focus on sustainability topics and facilitating pharma companies to complete their sustainability strategies with zero CO2 emission injection devices such as autoinjectors.

Sandra Lopes Guerreiro, PT

Global Head of Safety, Quality & Environment

ESTEVE

Sandra Lopes Guerreiro is a pharmacist by education and has more than 20 years of pharmaceutical industry experience in companies like GSK, Johnson & Johnson, and Novartis, leading teams in health safety and environment, quality, external suppliers, and operations.

At ESTEVE, a pharmaceutical company with seven state-of-the-art sites on three different continents and distribution to over 60 countries, net zero and the environmental pillar of the sustainability strategy are some of her responsibilities.

Sandra´s diverse background, enriched with several specialisation studies in product management, leadership, and pharmaceutical management, has led successful cultural and operational transformations, in the several companies she has worked for, being recognised through different awards.

Dr. Ester Lovsin Barle, CH

Global Head Product Sustainability and Stewardship

Takeda

Jürgen Wieland, CH

Development Environmental Sustainability Lead

Novartis

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Courtney Soulsby, UK

Global Director, Pharmaceutical Sustainability

British Standards Institution (BSI)

Richard Hall Hall, ES

Business Development/Chair – ASTM E55.11 Process Design

Rattiinox

Dr. Clare Mayes, FL

Sustainability Project Leader

AstraZeneca

Christopher Nial, IR

Senior Partner, EMEA Public Health Co-Lead

FINN Partners

Baijia Huang, DK

Global Environmental Lead

Novo Nordisk

Sam Maguire, UK

Sustainability & Impact lead

Clarasys

Ilaria Lo-Presti, UK

Head of Sustainability Engineering, Centre of Excellence

GSK

Bernd Mahlmann, CH

Associate Director, Account & Business Development

Ypsomed AG

Sandra Lopes Guerreiro, PT

Global Head of Safety, Quality & Environment

ESTEVE

BROCHURE   

Request the 2nd Sustainable Medicine & Environment Conference brochure and find out the latest topics and ideas that will be shared.    

Request

Please fill in your e-mail address below and we will process your request in a moment.

What our
participants
are saying

“I want to extend my gratitude and appreciation for providing such a quality platform for this very important part of our industry!” 

1
2
3
4
5

Robert B. Wood IV

Scientist II at FUJIFILM Diosynth Biotechnologies

"We had very interesting discussions with the different participants about our industry and the latest trends. Thanks to Vonlanthen for organizing another great 4.0 oriented event." 

1
2
3
4
5

Paolo Bento

Regional Sales Manager at ILC

"Big thank you to all the speakers at the #VLSustainMed Summit. Fantastic insights from a diverse group of industry experts and great presentations from all involved."   

1
2
3
4
5

Jessica Pearson

Occupational Hygiene Consultant at Armstrong Environmental